A biosignature tool helps women avoid unnecessary radiotherapy after undergoing lumpectomy for ductal carcinoma in situ (DCIS) ― and also identifies women who need more intense treatment. The ...
Lumpectomy plus radiotherapy is associated with a statistically significant reduced risk for breast cancer–related death compared with either lumpectomy or mastectomy alone in women with ductal ...
Sandie Walters’ breast cancer was diagnosed in 2007 during a routine screening mammogram, and soon after, the 58-year-old Grand Rapids, Mich., woman was sitting in a surgeon’s office. His ...
Women with ductal carcinoma in situ -- DCIS -- who later develop invasive breast cancer in the same breast are at higher risk of dying from breast cancer than those who do not develop invasive disease ...
Forbes contributors publish independent expert analyses and insights. I cover cancer science, treatments and attitudes. What’s controversial about DCIS is whether or not it should be considered ...
Bottom Line: Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma ...
Patients with ductal carcinoma in situ (DCIS) are often treated with radiation after lumpectomy, although it has remained unclear whether this can reduce the risk of dying from this noninvasive form ...
Mastectomy is done if the DCIS tumor is thought to be too large for lumpectomy. Mastectomy is also done if there is concern that the DCIS may involve other parts of the breast. In the U.S., about 75 ...
RICHMOND, Va. -- When a woman gets a mammogram, doctors may see something that doesn’t look right. She could end up having a lumpectomy or a mastectomy without ever being diagnosed with breast cancer.
In this Tuesday, July 31, 2012, file photo, a radiologist compares an image from earlier, 2-D technology mammogram to the new 3-D Digital Breast Tomosynthesis mammography in Wichita Falls, Texas. The ...
The widespread adoption of screening mammography in the United States has led to an associated increase in the incidence of both ductal carcinoma in situ (DCIS; stage 0 breast cancer) and early-stage ...
The hormone therapy tamoxifen can keep cancer from recurring in women with DCIS Tamoxifen following lumpectomy reduced risk of recurrence 44% to 51% Tamoxifen blocks estrogen receptors in cancer cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results